Search research articles
Contact Us
Filters
Showing results (11-20 of 194) with videos related to
Page
of 20
Sort By:
Journal of Bacteriology
|
April 27, 2000
NhaA, an Na(+)/H(+) antiporter involved in environmental survival of Vibrio cholerae
S Vimont, P Berche
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 4, 2001
Bactericidal activity of moxifloxacin against pneumococci
D Levy, P Berche
Microbiologia (Madrid, Spain)
|
June 1, 1996
The pathogenesis of infection by Listeria monocytogenes
C Rouquette, P Berche
Annales De L'Institut Pasteur. Microbiology
|
September 1, 1986
In vivo immunosuppression induced by a virulent strain of Yersinia pseudotuberculosis
M Simonet, P Berche
Medecine Et Maladies Infectieuses
|
May 26, 2005
[Opportunistic infections caused by Shewanella, new emergent bacteria]
H Pagniez, P Berche
Revue D'Epidemiologie Et De Sante Publique
|
January 1, 1992
The cholera epidemic in Ecuador: towards an endemic in Latin America
O Weil, P Berche
Drugs
|
January 1, 1995
In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis
O Gaillot, P Berche
The Journal of Antimicrobial Chemotherapy
|
May 1, 1996
Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group
P Gehanno, P Berche
La Nouvelle Presse Medicale
|
May 6, 1978
[Bacteriological aspects in the diagnosis and treatment of endocarditis (author's transl)]
J L Avril, P Berche
Annales D'Endocrinologie
|
March 23, 2010
[The return to life with insulin]
P Berche, J-J Lefrère
Page
of 20
Search research articles
Search
Showing results (11-20 of 194) with videos related to
Sort By:
Page
of 20
Journal of Bacteriology
|
April 27, 2000
NhaA, an Na(+)/H(+) antiporter involved in environmental survival of Vibrio cholerae
S Vimont, P Berche
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 4, 2001
Bactericidal activity of moxifloxacin against pneumococci
D Levy, P Berche
Microbiologia (Madrid, Spain)
|
June 1, 1996
The pathogenesis of infection by Listeria monocytogenes
C Rouquette, P Berche
Annales De L'Institut Pasteur. Microbiology
|
September 1, 1986
In vivo immunosuppression induced by a virulent strain of Yersinia pseudotuberculosis
M Simonet, P Berche
Medecine Et Maladies Infectieuses
|
May 26, 2005
[Opportunistic infections caused by Shewanella, new emergent bacteria]
H Pagniez, P Berche
Revue D'Epidemiologie Et De Sante Publique
|
January 1, 1992
The cholera epidemic in Ecuador: towards an endemic in Latin America
O Weil, P Berche
Drugs
|
January 1, 1995
In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis
O Gaillot, P Berche
The Journal of Antimicrobial Chemotherapy
|
May 1, 1996
Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group
P Gehanno, P Berche
La Nouvelle Presse Medicale
|
May 6, 1978
[Bacteriological aspects in the diagnosis and treatment of endocarditis (author's transl)]
J L Avril, P Berche
Annales D'Endocrinologie
|
March 23, 2010
[The return to life with insulin]
P Berche, J-J Lefrère
Page
of 20